Frederick A Beland Selected Research

malachite green

8/2006	Carcinogenicity of malachite green chloride and leucomalachite green in B6C3F1 mice and F344 rats.
7/2004	Genotoxicity of malachite green and leucomalachite green in female Big Blue B6C3F1 mice.
3/2003	Synthesis and characterization of N-demethylated metabolites of malachite green and leucomalachite green.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Frederick A Beland Research Topics

Disease

58	Neoplasms (Cancer) 12/2020 - 02/2002
46	Carcinogenesis 12/2020 - 05/2002
22	Body Weight (Weight, Body) 04/2022 - 03/2003
16	Non-alcoholic Fatty Liver Disease 11/2022 - 10/2010
16	Breast Neoplasms (Breast Cancer) 11/2014 - 04/2002
11	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 06/2007
5	Liver Neoplasms (Liver Cancer) 12/2020 - 10/2011
5	Fibrosis (Cirrhosis) 05/2016 - 11/2007
5	Endometrial Neoplasms (Endometrial Cancer) 07/2004 - 03/2003
4	Acquired Immunodeficiency Syndrome (AIDS) 01/2018 - 09/2009
4	Hyperplasia 01/2017 - 08/2007
4	Liver Cell Adenoma (Hepatocellular Adenoma) 11/2012 - 01/2005
3	Alcoholic Fatty Liver 01/2018 - 11/2007
3	Urinary Bladder Neoplasms (Bladder Cancer) 06/2014 - 05/2002
3	Carcinoma (Carcinomatosis) 11/2012 - 01/2005
3	Chemical and Drug Induced Liver Injury 08/2012 - 01/2009
3	Renal Insufficiency (Renal Failure) 07/2012 - 02/2011
3	Hemangiosarcoma (Angiosarcoma) 01/2005 - 04/2003
2	Inflammation (Inflammations) 04/2022 - 05/2016
2	Fatty Liver 01/2020 - 11/2007
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2017 - 10/2008
2	Leukemia 01/2017 - 08/2006
2	Hyponatremia 03/2016 - 06/2015
2	Liver Diseases (Liver Disease) 06/2013 - 06/2009
2	Infections 06/2009 - 03/2009
2	Adenoma (Adenomas) 08/2006 - 01/2005
2	Adenocarcinoma 01/2005 - 12/2002

Drug/Important Bio-Agent (IBA)

17	CarcinogensIBA 01/2020 - 01/2005
16	DNA AdductsIBA 01/2020 - 02/2002
15	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2002
15	MicroRNAs (MicroRNA)IBA 10/2017 - 06/2007
13	Tamoxifen FDA LinkGeneric 11/2014 - 02/2002
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2007
11	Biomarkers (Surrogate Marker)IBA 01/2020 - 02/2005
11	Pharmaceutical PreparationsIBA 04/2015 - 11/2007
9	Histones (Histone)IBA 01/2019 - 08/2007
7	Lysine (L-Lysine)FDA Link 01/2019 - 08/2007
7	Folic Acid (Vitamin M)FDA LinkGeneric 01/2019 - 01/2012
6	ArsenicIBA 12/2020 - 01/2018
6	IronIBA 11/2017 - 02/2011
5	Drinking WaterIBA 08/2019 - 01/2005
5	Choline (Choline Chloride)IBA 01/2019 - 01/2012
5	furanIBA 03/2017 - 04/2015
5	Zidovudine (Retrovir)FDA LinkGeneric 03/2014 - 04/2007
5	Estrogen Receptor Modulators (Antiestrogen)IBA 07/2004 - 10/2002
4	LipidsIBA 12/2020 - 03/2011
4	CytosineIBA 01/2019 - 05/2002
4	Triclosan (pHisoHex)FDA Link 11/2018 - 11/2014
4	NucleosidesIBA 01/2018 - 03/2009
4	ApoferritinsIBA 11/2017 - 02/2011
4	Pyrrolizidine AlkaloidsIBA 01/2017 - 04/2003
4	Ethanol (Ethyl Alcohol)IBA 01/2017 - 01/2005
4	CarbonIBA 07/2014 - 02/2002
4	4-biphenylamineIBA 06/2014 - 05/2002
4	Codon (Codons)IBA 11/2012 - 05/2002
4	Estrogens (Estrogen)FDA Link 03/2010 - 08/2006
3	glycidamideIBA 01/2019 - 05/2009
3	Reverse Transcriptase InhibitorsIBA 01/2018 - 03/2009
3	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2017 - 06/2014
3	EnzymesIBA 11/2013 - 08/2011
3	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2013 - 06/2010
3	melamineIBA 07/2012 - 02/2011
3	cyanuric acidIBA 07/2012 - 02/2011
3	2-Acetylaminofluorene (2 Acetylaminofluorene)IBA 10/2011 - 03/2009
3	malachite greenIBA 08/2006 - 03/2003
3	leucomalachite greenIBA 08/2006 - 03/2003
2	Sucrose (Saccharose)IBA 11/2022 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 03/2011
2	Nevirapine (Viramune)FDA Link 01/2018 - 01/2013
2	ChromatinIBA 01/2018 - 06/2007
2	Transferrin (beta 2 Transferrin)IBA 11/2017 - 02/2011
2	MethapyrileneIBA 11/2017 - 01/2017
2	Indicators and Reagents (Reagents)IBA 10/2017 - 07/2012
2	PPAR alphaIBA 01/2017 - 11/2014
2	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 05/2016 - 06/2014
2	tributyrinIBA 04/2016 - 07/2014
2	A-factor (Streptomyces)IBA 04/2016 - 10/2009
2	Tolvaptan FDA Link 03/2016 - 06/2015
2	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 03/2016 - 06/2015
2	Transferrin Receptors (Transferrin Receptor)IBA 01/2016 - 12/2014
2	Methionine (L-Methionine)FDA Link 07/2014 - 01/2012
2	8-Hydroxy-2'-DeoxyguanosineIBA 01/2014 - 10/2002
2	Iron-Regulatory Proteins (Iron-Responsive Element Binding Proteins)IBA 11/2013 - 02/2011
2	Cisplatin (Platino)FDA LinkGeneric 11/2013 - 05/2013
2	Glutamine (L-Glutamine)FDA Link 12/2012 - 06/2012
2	compound 968IBA 12/2012 - 06/2012
2	Benzo(a)pyreneIBA 11/2012 - 10/2002
2	melamine cyanurateIBA 04/2012 - 02/2011
2	Lamivudine (Epivir)FDA Link 03/2009 - 04/2007
2	alpha-hydroxytamoxifenIBA 11/2007 - 10/2002
2	NucleotidesIBA 11/2006 - 03/2003
2	Hormones (Hormone)IBA 07/2004 - 03/2003
2	riddelliineIBA 04/2004 - 04/2003
2	MutagensIBA 09/2003 - 10/2002
1	Immunoglobulin M (IgM)IBA 04/2022

Therapy/Procedure

2	Oral Administration 01/2017 - 04/2012
2	Therapeutics 12/2012 - 06/2012
2	Drug Therapy (Chemotherapy) 08/2011 - 11/2007
1	Intravenous Injections 04/2022
1	Subcutaneous Injections 04/2022